Cell adhesion molecules: potential therapeutic &amp; diagnostic implications (Q37038565)

17 August 2017

1 reference

title

Cell adhesion molecules: potential therapeutic & diagnostic implications (English)

1 reference

17 August 2017

0 references

1 reference

Shaker A Mousa

1

1 reference

17 August 2017

15 August 2007

1 reference

17 August 2017

Molecular Biotechnology

1 reference

17 August 2017

38

1 reference

17 August 2017

33-40

1 reference

17 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s12033-007-0072-7

17 August 2017

0 references

cites work

Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12033-007-0072-7

Role of platelet-endothelial cell adhesion molecule (PECAM) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12033-007-0072-7

MK-383 (L-700,462), a selective nonpeptide platelet glycoprotein IIb/IIIa antagonist, is active in man

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12033-007-0072-7

Oral platelet glycoprotein IIb/IIIa receptor antagonists: the present challenge is safety

21 January 2018

1 reference

12 December 2020

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

12 December 2020

Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys

1 reference

12 December 2020

Pharmacodynamic study of F(ab')2 fragments of murine monoclonal antibody 7E3 directed against human platelet glycoprotein IIb/IIIa in patients with unstable angina pectoris

1 reference

12 December 2020

Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist

1 reference

12 December 2020

The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro

1 reference

12 December 2020

Selectins: interpreters of cell-specific carbohydrate information during inflammation

1 reference

12 December 2020

Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules

1 reference

12 December 2020

ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le x

1 reference

12 December 2020

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction

1 reference

12 December 2020

Protective effects of oligosaccharides in P-selectin-dependent lung injury

1 reference

12 December 2020

Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men

1 reference

12 December 2020

The pharmacology of the integrins

1 reference

12 December 2020

Circulating adhesion molecules in disease

1 reference

12 December 2020

A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes

1 reference

12 December 2020

A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes

1 reference

12 December 2020

Inhibition of in vivo lymphocyte migration to inflammation and homing to lymphoid tissues by the TA-2 monoclonal antibody. A likely role for VLA-4 in vivo

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

12 December 2020

A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients

1 reference

12 December 2020

Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonist

1 reference

12 December 2020

Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Fab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 8 Pilot Study

1 reference

12 December 2020

Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function

1 reference

12 December 2020

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

1 reference

12 December 2020

Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.

1 reference

12 December 2020

Long-term administration of glycoprotein IIb/IIIa antagonists

1 reference

12 December 2020

Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo

1 reference

12 December 2020

Integrins and other cell adhesion molecules

1 reference

12 December 2020

Carbohydrate ligands of the LEC cell adhesion molecules

1 reference

12 December 2020

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

12 December 2020

In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury

1 reference

12 December 2020

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

12 December 2020

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

12 December 2020

Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock

1 reference

12 December 2020

Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia

1 reference

12 December 2020

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

1 reference

12 December 2020

An endothelial ligand for L-selectin is a novel mucin-like molecule

1 reference

12 December 2020

Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin

1 reference

12 December 2020

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

12 December 2020

10.1007/S12033-007-0072-7

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18095189